Animal Friends Insurance (AFI), a not-for-profit pet insurance business, has a High Court injunction which paves the way for its customers to make a smooth transition from the company's previous underwriters, Equine and Livestock Insurance Company (E&L), to Red Sands Insurance Company (Europe) Limited.
Equine and Livestock terminated their underwriting agreement with AFI in February 2008, citing unprofitablility of the book for them as the reason.
Negotiations over the transfer of the book to Red Sands Insurance Company (Europe) Limited foundered when E&L demanded £750,000 from AFI for the transfer and for their agreement not to solicit AFI customers.
Following legal advice AFI wrote to its customers offering to renew policies with Red Sands. This spawned letters to AFI customers from E&L which caused great confusion amongst customers as to what was happening with their insurance. The letters also offered first a 10% then a 20% discount to tempt AFI customers to renew with E&L and not to stay with AFI.
AFI therefore applied for an emergency injunction to prevent E&L making further contact with AFI customers (except in agreed situations, notably claims), to stop the escalating confusion and also to require them to acknowledge renewals advised to them by AFI into Red Sands and not to take further payments on those insurances. The application was successful.
Elaine Fairfax, Managing Director and Founder of AFI said: "I am delighted at the Court ruling. It has resolved the terrible confusion that followed E&L's letters to our customers. Unfortunately we know that some customers said they would renew with E&L thinking they were staying with us! Now we can simply renew our customers' policies with our new underwriters as we had originally intended to do at no inconvenience to them as they need do nothing if they want to stay with Animal Friends. They will enjoy exactly the same policy terms and premiums as before and our underwriters will even take on existing ongoing conditions where a policyholder has lifetime cover."
She added: "Although this has been a horrible experience we are delighted to have new underwriters as they have given us authority to handle everything in-house. For vets this means that Animal Friends will now be handling claims at our Wiltshire H.Q. We have a bespoke pet claims software systems and veterinary nurse staff to give the best possible service. We have the facility to pay claims swiftly direct into a customer's bank account or direct to a vet. It is also exciting that we shall be able to draw on Hollard's* international pet insurance experience to introduce some unique new products and ideas into the UK pet insurance market in the near future."
The introduction of the new Level 3 Diploma in Veterinary Nursing has seen an increase in numbers of both students and training practices, according to statistics released today by the RCVS.
Since January, the RCVS has approved over 30 more Training and Auxiliary Training Practices, bringing to a total of 1,559 the number of practices approved for veterinary nurse (VN) training. Scope for practices to train student VNs is increased through the emphasis on Auxiliary Training Practices (aTPs), an option for practices without the full facilities or caseload needed for student training. Students at aTPs complete their in-practice training at other aTPs or full Training Practices. Of the 31 new practices approved since January for student training, eight are aTPs.
The number of VN students enrolling with the RCVS has also increased, with almost double the number enrolling in January 2011, compared with January 2010. There were a total of 1,168 student enrolments in the 12 months from 1 February 2010, compared with 1,121 enrolments in the same period from 1 February 2009.
Libby Earle, Head of the RCVS Veterinary Nursing Department said: "The Level 3 Diploma has been in place for little more than six months, yet VN student numbers are already up. This bodes well for the supply of qualified, competent registered veterinary nurses demanded by veterinary practices, and for those keen to enter the veterinary nursing profession."
The qualification was introduced when the government abolished the National Vocational Qualification (NVQ) system last summer, forcing a change in the vocational qualifications for VNs. The resulting Level 3 Diploma is designed to better meet the needs of practices, colleges, and students themselves.
Veterinary surgeons are being called on to help recruit dogs for a clinical study called EPIC - the Evaluation of Pimobendan In dogs with Cardiomegaly caused by pre-clinical mitral valve disease (MVD).
The long-term study, which is supported by Boehringer Ingelheim, will assess whether using pimobendan in the pre-clinical phase of MVD has a benefit in extending the time to the onset of clinical signs. It involves 36 centres globally with the aim of recruiting 360 dogs in total. In order for dogs to be eligible for the study they must:
The three veterinary cardiologists from the UK involved in the randomised, double-blinded, placebo-controlled, parallel group study are Adrian Boswood MA VetMB DipECVIM-ca DVC MRCVS from the Royal Veterinary College (the RVC) in Hertfordshire, Sarah Smith MA VetMB DVC MRCVS from Sarah Smith Cardiology in Derbyshire and Mark Patteson MA VetMB, PhD DVC CertVR MRCVS from Heart Vets at Vale Referrals, Gloucestershire.
Adrian Boswood, veterinary cardiologist from RVC said: "The implications of this study for dogs and their owners could be enormous. If the research shows that pimobendan is effective before clinical signs of MMVD appear, this could lead to a new treatment option for practitioners."
For further information on the study or if you have a dog that may be suitable for the trial, please contact the nearest study investigator - Adrian Boswood on 01707 666605, Sarah Smith on 07515 359241 or Mark Patteson on 01453 547934.
Animalcare has launched Florgane, a novel, patented, long acting florfenicol 300mg/ml suspension which the company says has significant advantages over existing organic solvent-based florfenicol products on the market when used for the treatment and prevention of bovine respiratory disease (BRD).
Florgane is an aqueous, low viscosity advanced formulation, which, claims Animalcare, means that it is easier to inject even at temperatures as low as 5°C. Low temperature syringeability is important, as a large number of calves may need to be treated during colder weather at a time when the challenge from infectious agents is greatest. A syringeability study apparently demonstrated that Florgane is up to five times faster to administer when compared to the leading florfenicol non-aqueous formulation.
A paper on the treatment of naturally occurring respiratory disease with Florgane was presented recently at the British Cattle Veterinary Association (BCVA) Congress in Torquay. According to the company, the multi-centre field studies in Belgium, Germany and Italy, in over 400 cattle with bodyweights ranging between 73-180kg, demonstrated that Florgane given by a single intramuscular injection, at a 25% lower dose of 30mg/kg, is as efficacious as non-aqueous florfenicol 40mg/kg administered by subcutaneous injection, measured by treatment success and relapses.
Post mortem examination at day 27 (meat withdrawal of 37 days) confirmed that, despite being given via the intramuscular route, Florgane is well tolerated at the site of injection due to its aqueous base and physiological pH. Maximum volume per injection site is 15ml allowing calves up to 150kg to be treated.
Animalcare adds that a further advantage of Florgane is that it persists in plasma above the MICs for the three most common pathogens for significantly longer than conventional extended action 300mg/ml florfenicol solution preparations - thereby prolonging bacterial killing time. Therefore, owing to its improved bioavailability and excellent pharmacokinetics, Florgane can be given at an easy to remember dose of 1ml per 10kg.
Tony Liepman, Marketing Manager at Animalcare said: "Using Florgane will result in faster administration, resulting in less stress for the calves and a saving in time and money for the farmer."
Florgane is presented in polypropylene 100ml and 250ml multi-dose vials with a three year shelf-life.
For more information, visit www.animalcare.co.uk
Dechra Veterinary Products has launched a webcast about feline hyperthyoidism, given by Tim Williams MA VetMB MRCVS from the Feline Research Group at the Royal Veterinary College.
During the ten minute webcast, entitled: 'The highs and lows of feline hyperthyroidism', Tim presents new evidence that overdosing hyperthyroid patients can lead to iatrogenic hypothyroidism, making them more likely to develop azotaemia and consequently have a shorter survival time. He also discusses the diagnosis and potential consequences of iatrogenic hypothyroidism based on recent research conducted at the Feline Research Group, and provides a summary of suggested treatment protocols. Tim said: "I hope the webcast helps veterinary staff optimise their treatment of hyperthyroid cats in practice and avoid a one size fits all approach".
Dechra says that research from 400 first opinion practices has shown that hyperthyroidism is the most commonly diagnosed feline endocrinopathy, with an annual incidence of 6% in cats over nine years old.
Tim's webcast is the latest in a series of online educational materials on endocrinology launched by Dechra as part of its Dechra Academy training suite.The webcast is available at http://www.dechra.co.uk/hyperthyroidism
Vétoquinol, makers of Zylkène, a complementary feed for cats and dogs, has launched www.zylkenepet.co.uk, a new website with advice for pet owners about how they can help their pet deal with unsettling situations.
The website offers a behavioural quiz to help identify whether a pet may need help coping with any changes taking place. In addition, the site offers tips and advice from behavioural experts together with guides to helping pets cope with situations such as moving home, the introduction of a new baby or new people, travelling and holidays, coping with kennel and cattery stays and fireworks.
Krystyna Joyce, Product Manager at Vétoquinol, said: 'Owners often give Zylkène when their pet needs a bit of extra support to deal with unusual situations and changes to their routine, but there are also lots of practical things you can do that will improve a pet's experience further during that time. We wanted to make sure that information was readily available through a succinct, user friendly website.'
Zoetis Business Consulting has released figures showing that Profit Solver, its financial analysis tool, has delivered an average EBITDA (earnings before interest, taxes, depreciation and amortization) growth of 36% for the 28 UK practices that have used the new service since its launch.
Profit Solver was first launched in the USA, where the company says more than 300 practices have now benefited from the service.
Zoetis says that traditionally, veterinary practices have set their prices by simply adding a set mark-up, without knowing which services make a profit or loss and without understanding exactly how overall practice profit is being generated.
Profit Solver instead uses the practice’s own data to calculate the exact cost for the 130 most commonly performed veterinary services, representing 90% of the revenue generated by the practice. It then combines labour, inventory and equipment costs with time-and-motion studies for each service, and assesses the variance between cost and price to reveal profit or loss.
By using a collection of cost data, which staff perform which part of the procedure, how long the procedure takes and what equipment and materials are used, Profit Solver calculates the correct pricing to both cover costs and deliver a pre-determined profit margin.
Implementing Profit Solver is done with a Zoetis business consultant who guides the practice through the process, from data collection to examining the time-and-motion studies. They discuss the level of profitability the practice needs to deliver and help analyse prices to achieve this goal whilst preserving the price-point of highly competitive services and covering all the practice’s costs.
Ian Camm, Group Director of B&W Equine Vets in Gloucestershire heard about Profit Solver from a vet in a neighbouring practice who was impressed with how it had helped his business. Ian discussed Profit Solver with his Zoetis account manager and booked an appointment with Zoetis Business Consultant Anthea Pike who has helped him implement the software across B&W Equine Group.
He said: "Initially I was concerned that Profit Solver would suggest we put prices up where we felt that we would not be able to - people shop around for their veterinary services these days and many services are very price sensitive. The first stage in the process addressed this by looking at our figures, calculating the cost price for each procedure and then, by comparing with our fees charged, identified where we were losing money. The big question was whether we would be comfortable to increase our fees on loss-making procedures. The beauty of the system was that by looking at a large number of procedures which were done frequently, very small increases in fee would total to a significant improvement in the bottom line.
"The software has made us recognise where the real costs are and how to address these areas accordingly, for example we have identified that current stud packages are not profitable. One of the problems in arriving at true costs is the difficulty in accurately allocating time to various procedures when several different vets are involved or an expensive scanner is used, which can have a significant impact on the results. It’s early days, but I can already see the difference that Profit Solver could make to our bottom line and wouldn’t hesitate to recommend it providing the practice is prepared to make changes in light of the results. We are looking at improving our bottom line by a six figure sum over a 12 month period with what we hope, will be hardly noticeable price rises.”
For further information visit www.zoetis.co.uk/businessconsulting.
The Bella Moss Foundation (BMF) has launched a free practice hygiene audit tool.
The BMF Practice Hygiene Self Audit is a web-based assessment tool that allows staff to monitor cleanliness across the practice – from theatre and prep rooms to laundry and waiting rooms.
The tick sheet format allows staff to rate the hygiene protocols in each area, resulting in a room-by-room percentage hygiene score, as well as an overall contamination risk score.
The tool was developed by vet and RCVS Practice Standards Scheme (PSS) expert Pam Mosedale and VN lecturer Louise O'Dwyer, along with Edinburgh academic Tim Nuttall and Chris Laurence.
Pam said: "Given the relaunch of the PSS later in the year, which will include new modules on infection control, the BMF audit tool is especially timely.
"We hope that people will try the audit tool and it will lead them to have more of a team discussion about hygiene routines and protocols in practice. We know some areas get more attention than others - for example, how often do things like the toys in the waiting area really get cleaned?
“By using the audit, staff will easily be able to see what rooms/areas might need a bit more cleaning.
She added: "It's a simple no-frills tool but the whole idea is for it to be helpful and easy to use, so more practices are encouraged to have regular quantifiable monitoring systems in place to keep an eye on their hygiene protocols."
Co-creator Louise O'Dwyer said: “The BMF Practice Hygiene Self Audit will help ensure often overlooked aspects of cleaning and infection control are considered and implemented.
“It needs to be embraced by all members of staff, from non-clinical staff through to veterinary surgeons, as every individual has the potential to make an impact within their practice by taking action on infection control.”
To test the tool and see how clean your practice is, go to: www.thebellamossfoundation.com/practice-hygiene-self-audit
The new Mars Equestrian Veterinary Research Scholar Programme offers the opportunity to conduct research alongside some internationally-renowned experts in equine health and veterinary welfare while pursuing two advanced credentials: the Graduate Certificate in Animal Welfare and Behavior at Penn Vet during year one, followed by the Master of Research (MRes) program at the RVC in year two.
The RVC says the new format offers an exclusive opportunity for the candidate to refine their critical research skills and expand animal welfare knowledge while learning on location at both the RVC in England and Penn Vet’s New Bolton Center in Kennett Square, Pennsylvania, United States.
The RVC’s MRes programme gives students the chance to develop into scientists who can work well across interdisciplinary teams, tackling problems of practical relevance to veterinary and medical science. Many of the courses’ graduates go on to work in some of the world’s leading scientific research institutes, as well as within industry and government.
Professor Richard Bomphrey, Interim Vice Principal for Research at the RVC said: “I am delighted that the RVC is able to support this new transatlantic initiative for veterinary graduates following a generous donation from Mars Equestrian. It strengthens the ties between the RVC, the University of Pennsylvania and Mars Equestrian while providing an outstanding training and research opportunity. We look forward to welcoming the successful scholar and helping them to make an impact in equine research."
The Veterinary Research Scholar program is open to interested UK, US and international candidates holding a veterinary degree (DVM/VMD/BVSc or equivalent). The chosen candidate will receive an annual stipend and tuition as well as travel expenses.
The programme will commence in September 2021 in the United States before moving to the UK in October 2022 until its conclusion in September 2023.
The deadline to submit applications for consideration is 30th June 2021 or until an acceptable candidate is identified.
Applications should be sent to the Penn Vet’s Dr. Kyla Ortved atkortved@vet.upenn.edu.
The webinar is the first of several events which will focus attention on patients owned by the estimated 80% of owners who feel that their pets with canine osteoarthritis (OA) may be suffering from off-days that can be associated with breakthrough pain¹.
During the session, Matt will explain the impact breakthrough pain has on the pet and owner and how to approach it more effectively using analgesic and rehabilitation tools and strategies.
James Beaumont, Marketing Manager at Animalcare, said: “Veterinary surgeons have told us that they estimate that nearly half of their canine OA cases on daily NSAIDs experience breakthrough pain.²
"Additionally, a proportion of pet owners state their dogs experience off-days and believe their pet suffers as a result of the condition³."
Animalcare says that some of the main factors in osteoarthritis breakthrough pain can include variable plasma drug levels between doses, intermittent treatment protocols or poor owner adherence with the vet’s recommendation, flare-ups and disease progression.
To register for the event, visit: https://tinyurl.com/43bm8mdx. All those who register will also be able to view a recording and enter a free prize draw for the chance to win tickets to attend London Vet Show live in November.
Virbac Animal Health has developed a 'Yield Wheel' to show vets the additional income that farmers can achieve through taking a tailored and more flexible approach to the management of their dairy herd through the dry period.
The company says this approach is made easier using its Cephaguard DC dry cow therapy.
While a 60 day drying off period is required for some cows, others may not need to be withdrawn from milk production for the full period, including those with a high body condition score in late lactation, high yielders and older healthy cows with an increased tendency for weight gain. For cows in these categories, a shorter drying off period can mean additional days of milk production and extra income for the farmer with no negative impact on future lactations or the cow's overall health.
The Yield Wheel shows how production and income can be maximised on a sliding scale from a standard 60 day drying off period down to 36 days, the shortest drying off period. It also shows the benefits which can be gained in terms of reduced discarded milk days in the case of cows with an unclear calving date.
Cephaguard DC dry cow therapy is the most recent entrant to the dry cow therapy market. With its 35+1 day withdrawal period in milk, Virbac says it offers farmers increased flexibility for the management of dry periods.
Brigitte Goasduf, Ruminants Product Manager at Virbac said: "For dairy farmers, it's all about milk. They're looking to optimise production and reduce waste while also ensuring that they treat infections effectively at drying off and prevent new infections which may reduce yield during the next lactation.
We've produced the Yield Wheel to highlight the tangible benefits of taking a customised and more flexible approach to drying off using Cephaguard DC. The data is provided in a practical and straightforward way and demonstrates the potential yield benefits that can be achieved from an overall herd management and income perspective. We hope it will prove a useful tool."
A study by Janssen Animal Health has, according to the company, demonstrated that a leading herbal wormer had no demonstrable efficacy against common poultry worms1.
The trial, done to Good Clinical Practice (GCP) Standards, involved 48 chickens that had become naturally infected with three different poultry worms - Capillaria (Hairworm) species, Heterakis gallinarum (Caecal worm) and Ascaridia galii (Large roundworm). The birds were randomly assigned to one of three groups:
A. Flubenvet treated groupB. Herbal wormer treated groupC. Control (untreated) group.
The herbal treatment was administered for 3 days in-feed, as required by the 'on-pack' instructions and Flubenvet was given for 7 days as required on the product data sheet. Droppings were collected from individual birds and group pens at intervals for 2 weeks and examined for the presence of worm eggs
Table 1: Worm Count Summaries
Group
Minimum
Maximum
Median
A (Flubenvet treatment)
0.00
19.00
B (Herbal treatment)
108.00
1327.00
425.00
C (no treatment)
74.00
958.00
302.00
The results showed that very few worm eggs were present after one 7-day treatment with Flubenvet. In contrast, those that had no treatment or the herbal treatment still had hundreds of worm eggs in their droppings, suggesting that there were still many adult egg-laying worms present inside the chickens.
Janssen says poultry keepers who rely on preparations like this particular natural wormer may well be building up problems, as the additional numbers of worm eggs in the environment add to the infection pressure and can result in greater worm burdens for their birds. Birds with high worm burdens are more likely to become ill.
According to the Veterinary Medicines Regulations 2009 any product making veterinary medicinal claims needs to be licensed by the Veterinary Medicines Directorate. A licensed product has to show proven efficacy and safety for the animal species involved. Licensed veterinary medicines can be identified by their Vm number, which is shown on-pack. Products termed 'nutritional supplements', that are not licensed do not require the manufacturer to produce any proof of efficacy or safety. It is often easy to buy such products 'off the shelf' because they are not subject to any controls. Any poultry keeper who cares about the health and welfare of the birds is advised to think carefully about their choice of wormer and to seek advice from a vet pharmacist or Suitably Qualified Person (SQP).
1 Evaluation of the efficacy of flubendazole in comparison with a herbal wormer in the treatment of naturally acquired infections of Ascaridia galli, Heterakis gallinarum, and intestinal Capillaria spp in Chickens, Janssen Animal Health
Vetoquinol has announced that packs of Rubenal 300mg are now available in bottles of 60 tablets instead of the previous 20.
Rubenal, which was launched earlier this year, is a complementary nutritional feeding stuff for the support of renal function in case of chronic renal insufficiency in dogs and cats. It is used as an aid to the maintenance of the normal renal fibrous architecture.
Simon Boulton, Rubenal's product manager said: "This increased pack size is a direct result of customer consultation. It will make treatment more cost effective for dogs and allow a longer treatment period per pack purchased."
For further information please contact your Vetoquinol representative or telephone 0800 1698197.
There are 10 candidates standing this year and vets can vote for up to three of them until 5pm on Friday 21st April 2023:
The biographies and statements for each candidate are available at www.rcvs.org.uk/vetvote23 where each candidate has also answered two questions of their choice submitted by members of the profession.
The three candidates who receive the most votes will take up their four-year terms on RCVS Council at the RCVS Annual General Meeting on Friday 7th July 2023.
Any veterinary surgeons who have not received their voting email should contact CES directly on support@cesvotes.com stating which election they intend to vote in.
Bluevac-3 is an inactivated injectable vaccine indicated for the active immunisation against BTV-3 for use in sheep and cattle.
Ceva says it reduces viraemia, prevents mortality and reduces the clinical signs of BTV-3 in sheep and reduces viraemia in cattle.
In sheep, Bluevac-3 can be administered from two months of age and two doses of 2ml should be administered subcutaneously three weeks apart.
In cattle, the vaccine can be administered from two months of age and two doses of 4ml should be administered three weeks apart.
Onset of immunity occurs 21 days/three weeks after completion of primary vaccination in cattle and sheep.
The vaccine can be used in pregnancy in cows and ewes.
No negative impact on milk-yield after using the vaccine in lactating ewes and cows is expected.
Ceva developed the new vaccine in partnership with vaccine manufacturer CZV Vaccines and launched it in Europe early in the summer, to mitigate the impact of the disease already experienced in the Netherlands, Belgium, and Germany.
Craig Wright, ruminant business unit director at Ceva Animal Health, said: “In co-operation with our partner, CZV Vaccines, we have worked tirelessly to bring Bluevac-3 to the UK to help fight bluetongue which has the potential to cause severe financial loss to farmers.
"The availability of an effective vaccine is an essential tool to help suppress future outbreaks by reducing viraemia, preventing mortality and reducing the clinical signs of BTV-3.”
Licences to allow the use of the new vaccine will either be geographically targeted general licences, initially in high risk counties as part of a phased approach, or specific licences which can be applied for through APHA.
General licencing will be subject to risk assessment.
https://www.gov.uk/government/publications/summary-of-product-characteristics-for-bluevac-3-btv-3-vaccine-in-the-uk.
The Suckler Herd Performance Checklist is designed to help veterinary surgeons and farmers work together to draw up a workable action plan to address the main areas influencing optimum herd health and performance.
The new app works on tablet computers, as well as Apple and Android smartphones, and allows vets to e-mail audit results directly to farmer clients following an interactive on-farm assessment.
MSD Animal Health’s beef and youngstock marketing manager Robert Simpson said: “This additional engagement tool helps a vet assess performance across the five crucial time periods and processes impacting on the efficiency of beef suckler herds.
“For example, reducing calf morbidity and mortality rates in a suckler herd starts with management practices before conception.
"Optimum performance also requires following proper management protocols throughout the youngstock period from birth to weaning, including effective colostrum administration, vaccination, nutrition and hygiene.
“It can also be used to provide confidence to vets who are less experienced with suckler herds, allowing them to follow a structured evidence-based approach when on farm,” he said.
MSD says Lawsonia intracellularis is found on many finishing farms throughout the UK, and can affect weight gains, feed conversion ratios (FCR) and lead to increased mortality.
The new vaccine means that if piglets are vaccinated at three weeks, they will be protected against the bacteria from seven weeks.
Rubén Del Pozo Sacristán, technical manager for pigs at MSD Animal Health, said "Lawsonia intracellularis is present on most UK farms and can hamper a farm’s true potential as it spreads rapidly in faeces and on people or rodents, but symptoms can be hard to identify, as they’re often similar to many other diseases.
"Acute forms are often noticeable with symptoms such as diarrhoea or an increase in mortality, but the subclinical form, which is most common, can be hard to identify. Diarrhoea is not always present and often indicators are an increase in FCR and a reduction in weight gain leading to variation in pig performance, but this is similar to many other health issues.
"Administering an intramuscular vaccination will ensure every animal receives the correct dose, compared to other administrative routes. Porcilis Lawsonia can help reduce the clinical signs, production losses and mortality caused by Ileitis."
For more information on Porcilis Lawsonia, refer to the SPC sheet.
The RCVS has extended the deadline for nominations for the RCVS Queen's Medal to 31 January, to allow time for the nominations paperwork to be completed on return from the Christmas and New Year break.
RCVS CEO Nick Stace said: "We received more enquiries about the Queen's Medal over the Christmas period but appreciated that people might welcome a little extra time in the new year to complete and submit their nominations. We're certainly keen to allow anyone who wishes to make a nomination for this very special award the chance to do so."
The Queen's Medal, launched at the House of Lords last November, is a new Honour that will be awarded to a veterinary surgeon for a lifetime of outstanding contributions to the profession and who has dedicated their career to working above and beyond the call of duty in the fields of veterinary medicine or science, or related areas.
It is the most prestigious Honour that the RCVS can bestow, and will be awarded at RCVS Day in London in July.
Full details about the nominations process are available on the RCVS website (www.rcvs.org.uk/Queensmedal). Nominations should be received by the RCVS no later than 5pm on Friday, 31 January 2014.
Vet practices across the UK are being urged to get involved with Pet Smile Month to increase practice footfall and attract new clients in the tough economic climate.
Pet Smile Month, which runs during September 2009, is the world's largest veterinary-led pet health campaign and requires practices to offer a free dental check to pets by appointment during the month. The initiative aims to improve understanding of the importance of dental disease in dogs, cats and other pets and to encourage better dental care.
Over 1,500 UK practices have supported the campaign in recent years and some have reported increases of up to 10% in dental treatments in the months following the campaign. High profile sponsors; Pedigree, Whiskas, Petosan, Genitrix and Logic are supporting this year's Pet Smile Month.
There is no cost for participating and those practices which do will receive supplies of goody bags containing samples of Pedigree® DentaStixTM or Whiskas® DentaBitsTM, together with information leaflets, competitions and other special offers, to give to clients with their free dental health check.
Bob Partridge, the organiser of Pet Smile Month, is working with the sponsors on a major local radio publicity campaign at the end of August to raise awareness of Pet Smile Month and encourage pet owners to contact their local participating practice. The deadline to sign up is Monday 17 August 2009. Full details of how to get involved are available at www.petsmile.org or by calling 08714 24 25 26.
The company's Postgraduate Certificate (PgC) programme in Dentistry and Oral Surgery - delivered and awarded in partnership with Harper Adams University (HAU) and the International School of Veterinary Studies (ISVPS) - has been added to the list of qualifications conferring eligibility for applications for the AP Status in Small Animal Dentistry.
In addition, Improve's Postgraduate Diploma (PgD) in Advanced Veterinary Practice Sciences, achieved by obtaining the PgC in Small Animal Surgery, plus the ISVPS General Practitioner Advanced Certificate (GPAdvCert) in Small Animal Orthopaedic Surgery (together with two further modules with HAU), has also been recognised as an eligible entry qualification for application for the RCVS’ AP status in Small Animal Orthopaedics.
The GPAdvCert programme in Orthopaedic Surgery is due to start in September 2020 with the PgC programme in Dentistry and Oral Surgery commencing in January 2021.
Improve says that depending on the situation with coronavirus at the time, it will provide appropriate personal protective equipment for attending delegates and arrange for live sessions to be streamed online if physical attendance is not possible. Practical sessions will be rescheduled for the earliest possible date and the company has also revised its terms and conditions to provide maximum flexibility to delegates in case their circumstances change.
Photo: David Babington, Business Development Director, Improve International
The webinars will be delivered by board-certified equine diagnostic imaging specialists.
The first will cover equine cervical spinal radiographic interpretation presented by Erin Porter, DVM, DACVR, DACVR-EDI. Learning objectives include:
The second webinar will be on 7th February 2024, 1:00-2:00pm, when Marianna Biggi, DVM, PhD, FHEA, DipECVDI, MRCVS, will review a systemic approach to interpreting foot radiographs and the clinical significance of radiographic diagnoses.
In the final webinar on February 26th at 1:00pm, Lucy Meehan-Howard, BVSc, MSc, CertAVP(VDI), DipECVDI, MRCVS, will cover typical injuries to the fetlock in different kinds of horses and the optimal imaging strategy for each type of injury.
Information about all webinars is available here: welcome.vet-ct.com/equine-webinar-series. To learn more about VetCT, plus additional educational content and teleradiology services, visit https://uk.vet-ct.com/.
welcome.vet-ct.com/equine-webinar-series
The papers in the report cover things like: novel, 3D-printed anatomical implants for orthopaedics, osteoarthritis and clinical outcomes measures, movement disorders and Quality Improvement in cruciate ligament surgery.
John said: "For an independent veterinary practice to publish a report like this is, in my experience, novel, and it speaks to the culture and values of our practice.
"All of the references cited in the report are clinical research outputs that are directly relevant to practising vets so I hope this will be a useful collated resource.”
https://www.movementvets.co.uk/about-us/clinical-research
Roy Geary, regional director for Northern Europe (including the UK) at Ceva Animal Health, said: “The manufacturing of vaccines is a complex process that involves stringent quality control measures and adherence to regulatory guidelines.
"Unfortunately, the anticipated vaccine batch has failed to meet the quality expected to be suitable for release, which has temporarily affected the ability to meet the demands of the UK sheep market within the main seasonal vaccination period for EAE."
“We anticipate that the issue in supply will be resolved, with some stock potentially available later in the season, however we recognise that for some farmers the supply will arrive too late for them to use.
"We are encouraging vets to explore alternative means of safeguarding the health of their clients’ flocks during this period.
"We recommend implementing robust biosecurity measures and adhering to existing vaccination protocols for other preventable diseases to ensure the overall wellbeing of livestock.
“We will provide vet practices and the wider industry with regular updates as we progress toward a resolution and return to normal supply levels.”
No need for movie star looks, but if you've got a particular knack for taking blood pressure readings and are happy to appear on screen, the company is offering feline goodies and £50 Love2Shop vouchers in return for your help. And who knows, it could be the start of a second career in Hollywood.
Ceva is also asking veterinary surgeons and nurses for their top tips for taking blood pressure in cats, with the information potentially being featured in the film and shared with veterinary practices across the country.
For further information, please contact your local Ceva Animal Health territory manager or email cevauk@ceva.com.